Target Discovery & Therapeutic Design
Identify and validate novel targets for mAbs, ADCs, and precision therapies using biology-driven intelligence.
Oncology
Precision Oncology & Immuno-Oncology Solutions
Accelerating oncology drug discovery and clinical development through biologically grounded artificial intelligence.
The Challenge
Navigating Cancer’s Biological Complexity
Tumor heterogeneity and biological complexity make it difficult to identify the right biomarkers, stratify patients, and predict therapeutic response. Traditional approaches can miss clinically relevant patient subpopulations, contributing to costly, lengthy, and highly attritional drug development.
Bridging discovery and clinical success requires integrated biological intelligence that connects molecular insights with patient and clinical evidence.
Our Approach
From Biological Data to Actionable Therapeutic Insights
We enable biopharma organizations to move from biological data to actionable therapeutic insights. Our oncology domain experts use multi-scale biomedical knowledge graphs, foundation models, and translational AI to identify novel targets, optimize therapies, improve patient selection, and reduce clinical development risk.
001
Data Integration
Integrate proprietary and public omics, clinical, imaging, literature, and biomedical datasets.
002
AI & Scientific Reasoning
Apply foundation models, knowledge graphs, causal reasoning, and AI agents to generate and evaluate biological hypotheses.
003
Biological Intelligence
Prioritize targets, biomarkers, therapeutic combinations, and clinically relevant patient cohorts.
004
Translational Execution
Translate insights into actionable outputs across discovery, development, and clinical research.
Our Capabilities
Intelligence with Experts and AI
Combination Therapy Intelligence
Evaluate biological interactions and resistance mechanisms to identify rational therapeutic combinations.
Biomarker Discovery & Patient Stratification
Uncover biologically meaningful biomarkers and patient subgroups using multi-omics and clinical evidence.
Clinical Asset Rescue
Reanalyze historical trials and real-world evidence to identify new indications, patient segments, and optimization opportunities.
Clinical Trial Optimization
Use synthetic cohorts and predictive simulation to improve protocol design, patient selection, and enrollment strategies.
Translational Decision Support
Connect discovery, translational research, and clinical development through explainable, evidence-backed insights.
Enterprise Ready
Why ThinkBio.Ai®
Biology-first AI grounded in scientific reasoning
Explainable, traceable insights for R&D decisions
End-to-end intelligence across discovery and development
Enterprise integration across biopharma data and workflows
What Powers ThinkBio.Ai®’s Oncology Intelligence?
Biomedical Intelligence
Knowledge graphs, biomedical ontologies, DrugSuccess.Ai® reasoning, and domain-specific AI agents.
Scientific Intelligence
Literature synthesis, hypothesis generation, evidence summarization, and explainable biological reasoning.
Enterprise Cloud
Vertex AI, Gemini, BigQuery, Cloud Run, Healthcare APIs, and enterprise security and governance.
Data Integration
Omics, clinical trials, EHR/FHIR, imaging, real-world evidence, literature, and proprietary research.
Accelerate
Oncology Innovations
with ThinkBio.Ai®
TALK TO OUR TEAM
Stay Ahead with
ThinkBio.Ai®
Subscribe to our newsletter to receive the latest updates on products, sustainability efforts and services.